These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2801887)

  • 21. Production of tumor necrosis factor (TNF-alpha) and lymphotoxin (TNF-beta) by murine pre-B and B cell lymphomas.
    Laskov R; Lancz G; Ruddle NH; McGrath KM; Specter S; Klein T; Djeu JY; Friedman H
    J Immunol; 1990 May; 144(9):3424-30. PubMed ID: 2329277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical evidence of a role for transforming growth factor beta in the pathogenesis of nodular sclerosing Hodgkin's disease.
    Kadin ME; Agnarsson BA; Ellingsworth LR; Newcom SR
    Am J Pathol; 1990 Jun; 136(6):1209-14. PubMed ID: 2356855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of Hodgkin's disease derived cell line HDLM-2.
    Drexler HG; Gignac SM; Hoffbrand AV; Leber BF; Norton J; Lok MS; Minowada J
    Recent Results Cancer Res; 1989; 117():75-82. PubMed ID: 2602652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant CD30 ligand and CD40 ligand share common biological activities on Hodgkin and Reed-Sternberg cells.
    Gruss HJ; Ulrich D; Braddy S; Armitage RJ; Dower SK
    Eur J Immunol; 1995 Jul; 25(7):2083-9. PubMed ID: 7621881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-1 and tumor necrosis factor-alpha in the Reed-Sternberg cells of Hodgkin's disease. Correlation with clinical and morphological "inflammatory" features.
    Benharroch D; Prinsloo I; Apte RN; Yermiahu T; Geffen DB; Yanai-Inbar I; Gopas J
    Eur Cytokine Netw; 1996; 7(1):51-7. PubMed ID: 8704095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in the biological activity of TNF alpha and TNF beta correlate with their different abilities for binding to the target cells.
    Kircheis R; Milleck J; Korobko VG; Shingarova LN; Schmidt HE
    Eur Cytokine Netw; 1992; 3(4):381-90. PubMed ID: 1330049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
    Georgakis GV; Li Y; Rassidakis GZ; Martinez-Valdez H; Medeiros LJ; Younes A
    Clin Cancer Res; 2006 Jan; 12(2):584-90. PubMed ID: 16428504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin 9 is expressed by primary and cultured Hodgkin and Reed-Sternberg cells.
    Gruss HJ; Brach MA; Drexler HG; Bross KJ; Herrmann F
    Cancer Res; 1992 Feb; 52(4):1026-31. PubMed ID: 1737332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine (interleukin-1 alpha, interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6)-possessing cells in lymph nodes of malignant lymphoma.
    Takeshita M; Sumiyoshi Y; Masuda Y; Ohshima K; Yoshida T; Kikuchi M; Müller H
    Pathol Res Pract; 1993 Feb; 189(1):18-25. PubMed ID: 8516212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine regulation of tumor necrosis factor-alpha and -beta (lymphotoxin)-messenger RNA expression in human peripheral blood mononuclear cells.
    Kasid A; Director EP; Stovroff MC; Lotze MT; Rosenberg SA
    Cancer Res; 1990 Aug; 50(16):5072-6. PubMed ID: 1696166
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hodgkin's disease derived cell lines HDLM-2 and L-428: comparison of morphology, immunological and isoenzyme profiles.
    Drexler HG; Gaedicke G; Lok MS; Diehl V; Minowada J
    Leuk Res; 1986; 10(5):487-500. PubMed ID: 3713248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for the release of autocrine growth factor(s) by Hodgkin's cell lines.
    Imam SA; Taylor CR
    Anticancer Res; 1996; 16(4A):1727-32. PubMed ID: 8712691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of interleukin-2R alpha and interleukin-2R beta in Hodgkin's disease.
    Tesch H; Günther A; Abts H; Jücker M; Klein S; Krueger GR; Diehl V
    Am J Pathol; 1993 Jun; 142(6):1714-20. PubMed ID: 8506943
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a cell surface molecule expressed on B-lymphocytes and Hodgkin's cells.
    Imam A; Stathopoulos E; Holland SL; Epstein AL; Taylor CR
    Cancer Res; 1990 Mar; 50(5):1650-7. PubMed ID: 1689214
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hodgkin's disease derived cell lines: a review.
    Drexler HG; Minowada J
    Hum Cell; 1992 Mar; 5(1):42-53. PubMed ID: 1419951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genotypes and immunophenotypes of Hodgkin's disease-derived cell lines.
    Drexler HG; Leber BF; Norton J; Yaxley J; Tatsumi E; Hoffbrand AV; Minowada J
    Leukemia; 1988 Jun; 2(6):371-6. PubMed ID: 3131596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
    van den Berg A; Visser L; Poppema S
    Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell line.
    Wendtner CM; Schmitt B; Gruss HJ; Druker BJ; Emmerich B; Goodwin RG; Hallek M
    Cancer Res; 1995 Sep; 55(18):4157-61. PubMed ID: 7545087
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant expression of T cell and B cell markers in myelocyte/monocyte/histiocyte-derived lymphoma and leukemia cells. Is the infrequent expression of T/B cell markers sufficient to establish a lymphoid origin for Hodgkin's Reed-Sternberg cells?
    Hsu SM; Hsu PL
    Am J Pathol; 1989 Jan; 134(1):203-12. PubMed ID: 2492402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.
    Bialas T; Kolitz J; Levi E; Polivka A; Oez S; Miller G; Welte K
    Cancer Res; 1988 Feb; 48(4):891-8. PubMed ID: 3257413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.